News

Filter

Current filters:

Synagis

1 to 9 of 67 results

PDL expects 18% rise in 2nd-qtr revenues

09-06-2009

US drug developer PDL BioPharma says that its expects its second-quarter 2009 revenue to total $125.0…

AvastinbevacizumabLucentisNatalizumabPalivizumabRanibizumab InjectionRocheSynagisTysabri

PDL returns to profit on sales up 31%

16-03-2009

USA-based biotechnology company PDL BioPharma has returned to profit in 2008, on a 31% year-on-year jump…

AvastinbevacizumabHerceptinNatalizumabPalivizumabSynagistrastuzumabTysabri

Genentech settles Cabilly patent case

16-06-2008

US biotechnology giant Genentech says that it has settled its patent litigation with MedImmune involving…

GenentechPalivizumabRocheSynagis

PDL's 1st-qtr 2008 net loss triples to $62M

26-05-2008

US drugmaker PDL BioPharma's first-quarter 2008 net loss, including results from discontinued operations,…

GenentechHerceptinNatalizumabPalivizumabSynagistrastuzumabTysabri

1 to 9 of 67 results

Back to top